Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)429-439
JournalEuropean Journal of Endocrinology
Volume170
Issue number3
DOIs
Publication statusPublished - 2014

Cite this